WallStreetZenWallStreetZen

NASDAQ: PHAR
Pharming Group Nv Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Pharming Group Nv revenue was $364.44M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $86.0M, down 10.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PHAR annual revenue was $309.6M, with 13.6% growth year-over-year.

PHAR past revenue growth

How has PHAR's revenue growth performed historically?

Company
24.13%
Industry
1,361.15%
Market
34.96%
PHAR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PHAR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PHAR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PHAR revenue history

Current Revenue
$348.6M
Current Earnings
-$15.3M
Current Profit Margin
-4.4%

Be the first to know when PHAR announces revenue.

PHAR Revenue History By Year

PHAR Yearly RevenuePHAR RevenuePHAR ChangePHAR Revenue Growth
2024-12-31$309.58M$37.01M+13.58%
2023-12-31$272.57M$53.83M+24.61%
2022-12-31$218.75M-$7.24M-3.20%
2021-12-31$225.99M-$32.76M-12.66%
2020-12-31$258.75M$45.95M+21.59%
2019-12-31$212.80M$57.47M+37.00%
2018-12-31$155.32MN/AN/A

1 of 1

Pharming Group Nv Revenue FAQ

What was PHAR's revenue last quarter?

On Invalid Date, Pharming Group Nv (NASDAQ: PHAR) reported Q1 2025 revenue of $85.97 million up 42.29% year over year. In the same quarter last year, Pharming Group Nv's revenue was $60.42 million.

What was Pharming Group Nv's revenue in 2024?

Pharming Group Nv's annual revenue for the twelve months ending Dec 31, 2024 was $309.58 million, a 13.58% increase year over year.

How much does Pharming Group Nv make in a day?

Based on Pharming Group Nv annual revenue for the past five years, PHAR makes an average of $704,461.38 per day.

What was Pharming Group Nv's annual revenue growth in the past year?

As of Q2 2025, Pharming Group Nv's revenue has grown 24.13% year over year. This is 1,337.01 percentage points lower than the US Biotechnology industry revenue growth rate of 1,361.15%. Pharming Group Nv's revenue in the past year totaled $364.44 million.

How much does Pharming Group Nv make in a year?

Pharming Group Nv's revenue by year for the past five years is:
  • Pharming Group Nv's revenue for the twelve months ending Dec 31, 2024 was $309.58 million, a 13.58% increase year over year.
  • Pharming Group Nv's annual revenue for Dec 31, 2023 was $272.57 million, a 24.61% increase from 2022.
  • Pharming Group Nv's annual revenue for 2022 was $218.75 million, a 3.2% decrease from 2021.
  • Pharming Group Nv's annual revenue for 2021 was $225.99 million, a 12.66% decrease from 2020.
  • Pharming Group Nv's annual revenue for 2020 was $258.75 million, a 21.59% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.